XML 36 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1

SEGMENT INFORMATION (Tables)

3 Months Ended

Jan. 31, 2024

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

SCHEDULE OF SEGMENT INFORMATION

		2024				2023
		For the Three Months Ended January 31,
		2024				2023
Net loss:
CAR-T Therapeutics		$	(1,525	)		$	(911	)
Cancer Vaccines			(1,756	)			(958	)
Anti-Viral Therapeutics			-				(482	)
Other			(9	)			(3	)
Total		$	(3,290	)		$	(2,354	)
Net loss		$	(3,290	)		$	(2,354	)
Total operating costs and expenses		$	3,609			$	2,556
Less non-cash share-based compensation			(1,260	)			(1,063	)
Operating costs and expenses excluding non-cash share-based compensation		$	2,349			$	1,493
Operating costs and expenses excluding non-cash share based compensation expense:
CAR-T Therapeutics		$	1,128			$	598
Cancer Vaccines			1,213				588
Anti-Viral Therapeutics			-				305
Other			8				2
Total		$	2,349			$	1,493
Operating costs and expenses excluding non-cash share based compensation		$	2,349			$	1,493

		January 31, 2024				October 31, 2023
Total assets:
CAR-T Therapeutics		$	12,124			$	7,523
Cancer Vaccines			13,162				17,215
Anti-Viral Therapeutics			-				700
Other			86				84
Total		$	25,372			$	25,522
Total assets		$	25,372			$	25,522

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-25

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration